Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
![Elemental analysis by Metallobalance provides a complementary support layer over existing blood biochemistry panel-based cancer risk assessment [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2021/12247/1/fig-1-full.png "Elemental analysis by Metallobalance provides a complementary support layer over existing blood biochemistry panel-based cancer risk assessment [PeerJ]")
Elemental analysis by Metallobalance provides a complementary support layer over existing blood biochemistry panel-based cancer risk assessment [PeerJ]
The evolution and future of influenza pandemic preparedness | Experimental & Molecular Medicine
Transformations of Biomass, Its Derivatives, and Downstream Chemicals over Ceria Catalysts | ACS Catalysis
CA 19-9 Antigen - an overview | ScienceDirect Topics
CA 19-9: Reference Range, Interpretation, Collection and Panels
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
US Route 199; the Redwood Highway
IJMS | Free Full-Text | Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives
Clinical significance and diagnostic capacity of serum TK1, CEA, CA 19-9 and CA 72-4 levels in gastric and colorectal cancer patients
Microfluidic Magnetic Spatial Confinement Strategy for the Enrichment and Ultrasensitive Detection of MCF-7 and Escherichia coli O157:H7 | Analytical Chemistry
3M™ Value Duct Tape 1900, Silver, 50 mm x 50 m | 3M
CA 19-9 – Pancreatic Cancer Action Network
Oncofetal reprogramming in tumour development and progression | Nature Reviews Cancer
Biology | Free Full-Text | Genetic Diversity Trends in the Cultivated Potato: A Spatiotemporal Overview
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases - Al-Shamsi - Journal of Gastrointestinal
Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study | BMC Cancer | Full Text
Textile Marker, 5 colours
Circulating extracellular vesicles are effective biomarkers for predicting response to cancer therapy - eBioMedicine
CA19-9 - Wikipedia
